PTPN22 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9Y2R2 |
---|---|
Clone Names | 100617084 |
Gene ID | 26191 |
---|---|
Other Names | Tyrosine-protein phosphatase non-receptor type 22, Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP, Lymphoid phosphatase, LyP, PEST-domain phosphatase, PEP, PTPN22, PTPN8 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | PTPN22 |
---|---|
Synonyms | PTPN8 |
Function | Acts as a negative regulator of T-cell receptor (TCR) signaling by direct dephosphorylation of the Src family kinases LCK and FYN, ITAMs of the TCRz/CD3 complex, as well as ZAP70, VAV, VCP and other key signaling molecules (PubMed:16461343, PubMed:18056643). Associates with and probably dephosphorylates CBL. Dephosphorylates LCK at its activating 'Tyr-394' residue (PubMed:21719704). Dephosphorylates ZAP70 at its activating 'Tyr-493' residue (PubMed:16461343). Dephosphorylates the immune system activator SKAP2 (PubMed:21719704). Positively regulates toll-like receptor (TLR)-induced type 1 interferon production (PubMed:23871208). Promotes host antiviral responses mediated by type 1 interferon (By similarity). Regulates NOD2-induced pro-inflammatory cytokine secretion and autophagy (PubMed:23991106). Acts as an activator of NLRP3 inflammasome assembly by mediating dephosphorylation of 'Tyr-861' of NLRP3 (PubMed:27043286). Dephosphorylates phospho-anandamide (p-AEA), an endocannabinoid to anandamide (also called N-arachidonoylethanolamide) (By similarity). |
Cellular Location | Cytoplasm {ECO:0000250|UniProtKB:P29352}. |
Tissue Location | Expressed in bone marrow, B and T-cells, PBMCs, natural killer cells, monocytes, dendritic cells and neutrophils (PubMed:15208781). Both isoform 1 and 4 are predominantly expressed in lymphoid tissues and cells. Isoform 1 is expressed in thymocytes and both mature B and T-cells. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes of member of the non-receptor class 4subfamily of the protein-tyrosine phosphatase family. The encodedprotein is a lymphoid-specific intracellular phosphatase thatassociates with the molecular adapter protein CBL and may beinvolved in regulating CBL function in the T-cell receptorsignaling pathway. Mutations in this gene may be associated with arange of autoimmune disorders including Type 1 Diabetes, rheumatoidarthritis, systemic lupus erythematosus and Graves' disease.Alternatively spliced transcript variants encoding distinctisoforms have been described.
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Andersen, M.K., et al. Diabetes Care 33(9):2062-2064(2010)Bianco, B., et al. Scand. J. Immunol. 72(3):256-259(2010)Pradhan, V., et al. J Postgrad Med 56(3):239-242(2010)Sfar, I., et al. Arch Inst Pasteur Tunis 86 (1-4), 51-62 (2009) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.